search innovation
Improving stem cell culture using carnivorous plants
keywords: stem cell culture improving
offer number: P-411, P-435, P-439

Mesenchymal Stem Cells (MSCs) are multipotent precursor cells with the unique capacity to self-renew, proliferation and transformation into specialized cells present in many body tissues, such as muscle, adipose tissue, fibroblasts, cartilage, tendons, and nervous tissue. They are also characterized by the ability to affect the immune system by secretion of compounds that support the immune response directed among others against bacteria and parasites. They have properties enabling the secretion of chemical compounds that stimulate the formation of new blood vessels. All these attributes make them applicable in regenerative medicine, transplantology and in the treatment of many diseases. The umbilical cord blood and Wharton’s jelly MSCs are the sources from which MSCs are obtained. Due to the small amount of MSCs in the starting material, it is necessary to lead in vitro cultures to obtain sufficient numbers of cells that can be administered to the patient. Methods of isolation and culture of mesenchymal stem cells, including the growth medium, play a crucial role in obtaining the appropriate biological material that guarantees therapeutic success. Therefore, continuous improvement of procedures for isolating and in vitro culturing of MSCs is extremely important.

 

commercial utility:

The subject of the offer is a method of culturing mesenchymal stem cells using secretions from carnivorous plants, which increase cell adherence and proliferation, counteract their transformation into specialized cells, therefore, they longer maintain their pluripotency.

The method of improving stem cell culture using carnivorous plants is the subject of the three patent applications. Further research on technology development is carried out at the Faculty of Biology, Jagiellonian University and Department of Clinical Genetics, Medical University of Lublin. Technology Transfer Center CITTRU UJ is looking for entities interested in cooperation in the further development and commercialization of the invention, in particular, those willing to join to research and development process aimed at rescaling the system to industrial.


Pamphlet with results of the experimentsPamphlet with results of the experiments

Logos od European Funds, Republic of Poland, Inkubator Innowacyjności 2.0, European Union

field of science: biology, biotechnology
forms of protection: patent application
technological maturity: tests - laboratory trials
property rights: co-ownership
variants of cooperation: license, sale

information / broker of Jagiellonian University

name and surname: Renata Bartoszewicz
phone number: +48 12 664 42 08; +48 515 493 518
NEWS
latest information
ATOMIN 2.0 - ATOMic scale science for the INnovative economy

A center for atomic-scale materials research for an innovative economy, the so-called Atomin 2.0 project, has been established as a part of a joint venture of the Faculty of Chemistry and the Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University.

Big Pharma Day online
Big Pharma Day online is an industry meeting on the development of drug projects, organized by CTT CITTRU, happening on March 25, 2021. The event will include expert presentations and individual meetings.
A new, effective method for obtaining common ash cuttings
Discover a new technology for obtaining cuttings of common ash developed by the interdisciplinary research team from the Jagiellonian University and the University of Agriculture in Krakow.
CITTRU team
Our employees
PARTNERS
Innovation Forum KrakówKlaster Lifescience KrakówWolves SummitPACTTJagiellońskie Centrum Innowacji
Contact
GET IN TOUCH WITH US
Centre for Technology Transfer CITTRU
Jagiellonian University in Kraków - POLAND
ul. Bobrzyńskiego 12,
30-348 Kraków

PHONE:
+48 12 664 42 00
E-MAIL:
cittru@uj.edu.pl
Fundusze EuropejskieMNiSWInkubator InnowacyjnościUnia Europejska